ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 155 filers reported holding ASCENDIS PHARMA A/S in Q3 2020. The put-call ratio across all filers is 0.38 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $356,035,825 | +9.8% | 3,802,177 | +4.7% | 2.42% | +17.8% |
Q2 2023 | $324,130,268 | -3.9% | 3,631,712 | +15.4% | 2.06% | -13.6% |
Q1 2023 | $337,327,617 | -12.5% | 3,146,126 | -0.4% | 2.38% | -19.9% |
Q4 2022 | $385,707,058 | +28.3% | 3,158,168 | +8.5% | 2.98% | +24.6% |
Q3 2022 | $300,561,000 | +16.0% | 2,910,724 | +4.4% | 2.39% | +17.0% |
Q2 2022 | $259,201,000 | -16.2% | 2,788,309 | +5.8% | 2.04% | +3.0% |
Q1 2022 | $309,247,000 | -13.0% | 2,635,027 | -0.2% | 1.98% | -6.2% |
Q4 2021 | $355,285,000 | +5.6% | 2,640,934 | +25.1% | 2.11% | +4.0% |
Q3 2021 | $336,551,000 | +26.9% | 2,111,493 | +4.7% | 2.03% | +27.8% |
Q2 2021 | $265,195,000 | +10.2% | 2,015,927 | +7.9% | 1.59% | +6.1% |
Q1 2021 | $240,708,000 | -16.6% | 1,867,693 | +8.0% | 1.50% | -12.6% |
Q4 2020 | $288,510,000 | +4.5% | 1,729,881 | -3.3% | 1.71% | -4.3% |
Q3 2020 | $276,198,000 | +29.8% | 1,789,774 | +24.4% | 1.79% | +22.2% |
Q2 2020 | $212,779,000 | +38.6% | 1,438,665 | +5.5% | 1.46% | +8.2% |
Q1 2020 | $153,526,000 | -12.5% | 1,363,342 | +8.1% | 1.35% | +8.2% |
Q4 2019 | $175,396,000 | +62.0% | 1,260,756 | +12.2% | 1.25% | +44.1% |
Q3 2019 | $108,269,000 | -3.2% | 1,124,054 | +15.7% | 0.87% | +3.0% |
Q2 2019 | $111,897,000 | +38.5% | 971,752 | +41.5% | 0.84% | +36.9% |
Q1 2019 | $80,806,000 | +139.2% | 686,545 | +27.3% | 0.62% | +113.5% |
Q4 2018 | $33,776,000 | -18.1% | 539,120 | -7.3% | 0.29% | -0.3% |
Q3 2018 | $41,222,000 | +46.0% | 581,734 | +37.0% | 0.29% | +37.0% |
Q2 2018 | $28,243,000 | – | 424,575 | – | 0.21% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 7,387,900 | $1,177,557,000 | 16.32% |
Q Global Advisors, LLC | 66,714 | $10,634,000 | 8.85% |
Ghost Tree Capital, LLC | 120,000 | $19,127,000 | 5.59% |
Vivo Capital, LLC | 760,606 | $121,233,000 | 5.44% |
Spyglass Capital Management LLC | 1,378,887 | $219,781,000 | 5.04% |
Avoro Capital Advisors LLC | 1,980,000 | $315,592,000 | 4.96% |
Eversept Partners, LP | 445,203 | $70,960,906 | 4.93% |
Sofinnova Investments, Inc. | 499,824 | $79,667,000 | 4.72% |
Eventide Asset Management | 1,748,648 | $278,717,000 | 3.68% |
Baker Brothers Advisors | 4,541,604 | $723,886,000 | 3.18% |